Patient Square Capital Leads $71M Investment Round in Resolve
With this series B round of financing, Resolve Biosciences has now raised over $100 million.
After clicking on a story, use the back arrow in your browser to return to your search results. Use phrases "in quotes" or the tools below to better filter your results.